Trump Pauses 50% Canada Tariffs as U.S.-Canada Trade Deal Nears
Donald Trump has delayed planned 50% tariffs on nearly $20 billion of Canadian imports for three days as the U.S. and Canada work to finalize a new trade agreement.
The ultimate online hub for entrepreneurs, startups and companies looking for information.
Donald Trump has delayed planned 50% tariffs on nearly $20 billion of Canadian imports for three days as the U.S. and Canada work to finalize a new trade agreement.
Key Highlights Introduction Grupo Televisa is urging Mexico’s Telecommunications Regulatory Commission to improve the design of the country’s first industrial 5G spectrum auction. The company believes the current proposal may create unnecessary financial and administrative barriers that could reduce participation and delay investment in private wireless networks. The intervention highlights Televisa’s growing role in Mexico’s…
The Indian Premier League’s business value has climbed 11% to $20.6 billion, driven by rising franchise prices.
New York City has launched more than 50 small-business reforms aimed at reducing permits, paperwork, fines, and licensing burdens for businesses.
South Korean retail investors are suffering steep losses after leveraged ETFs tied to SK Hynix and Samsung reversed sharply.
Key Highlights Introduction Honda is preparing for a major shift in its U.S. electric vehicle strategy by ending sales of the Prologue after the 2026 model year. Although the Prologue became one of Honda’s fastest-selling EVs and ranked among the top-selling electric models in the country, the company always treated it as a temporary bridge…
Liberty Latin America shareholders re-elected Alfonso de Angoitia to the board, approved KPMG as auditor, and backed the company’s 2026 Incentive Plan.
Hellmann Worldwide Logistics plans to grow its business in Japan and across APAC.
Elon Musk has become the world’s first trillionaire after SpaceX’s blockbuster market debut, marking a new milestone in the rise of tech wealth
Sigma Healthcare has ended talks to buy Boots, walking away from a deal valued at about $10 billion and leaving the future of the U.K. pharmacy chain uncertain.